VRCA Historical PE Ratio image   This VRCA PE ratio history page last updated 11/11/2025
VRCA Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2025
8/12/2025
6.820.251.006.8
Q1 2025
5/13/2025
5.50-0.80-3.20NA
Q4 2024
3/11/2025
6.48-1.80-7.20NA
Q3 2024
11/4/2024
14.30-4.30-17.20NA
Q2 2024
8/14/2024
31.20-3.10-12.40NA
Q1 2024
5/13/2024
95.60-3.80-15.20NA
Q4 2023
2/29/2024
52.70-5.30-21.20NA
Q3 2023
11/9/2023
32.10-3.20-12.80NA
Q2 2023
8/8/2023
52.90-2.10-8.40NA
Q1 2023
5/9/2023
65.40-1.30-5.20NA
Q4 2022
3/6/2023
72.70-1.40-5.60NA
Q3 2022
11/7/2022
23.800.702.808.5
Q2 2022
8/11/2022
36.30-3.70-14.80NA
Q1 2022
5/9/2022
60.80-2.50-10.00NA
Q4 2021
3/2/2022
85.90-3.50-14.00NA
Q3 2021
11/12/2021
123.30-4.70-18.80NA
Q2 2021
8/10/2021
113.30-4.30-17.20NA
Q1 2021
5/7/2021
115.00-4.00-16.00NA
Q4 2020
3/4/2021
133.40-5.20-20.80NA
Q3 2020
11/9/2020
78.40-4.20-16.80NA
Q2 2020
8/5/2020
67.20-3.80-15.20NA
Q1 2020
5/7/2020
104.60-3.90-15.60NA
Q4 2019
3/13/2020
91.10-3.10-12.40NA
Q3 2019
11/6/2019
142.20-2.40-9.60NA
Q2 2019
8/7/2019
109.30-2.80-11.20NA
Q1 2019
5/7/2019
90.50-3.00-12.00NA
Q4 2018
3/7/2019
117.60-3.00-12.00NA
Q3 2018
11/7/2018
133.40-2.70-10.80NA
VRCA PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2025
8/12/2025
6.820.25-6.65NA
Q1 2025
5/13/2025
5.50-0.80-10.00NA
Q4 2024
3/11/2025
6.48-1.80-13.00NA
Q3 2024
11/4/2024
14.30-4.30-16.50NA
Q2 2024
8/14/2024
31.20-3.10-15.40NA
Q1 2024
5/13/2024
95.60-3.80-14.40NA
Q4 2023
2/29/2024
52.70-5.30-11.90NA
Q3 2023
11/9/2023
32.10-3.20-8.00NA
Q2 2023
8/8/2023
52.90-2.10-4.10NA
Q1 2023
5/9/2023
65.40-1.30-5.70NA
Q4 2022
3/6/2023
72.70-1.40-6.90NA
Q3 2022
11/7/2022
23.800.70-9.00NA
Q2 2022
8/11/2022
36.30-3.70-14.40NA
Q1 2022
5/9/2022
60.80-2.50-15.00NA
Q4 2021
3/2/2022
85.90-3.50-16.50NA
Q3 2021
11/12/2021
123.30-4.70-18.20NA
Q2 2021
8/10/2021
113.30-4.30-17.70NA
Q1 2021
5/7/2021
115.00-4.00-17.20NA
Q4 2020
3/4/2021
133.40-5.20-17.10NA
Q3 2020
11/9/2020
78.40-4.20-15.00NA
Q2 2020
8/5/2020
67.20-3.80-13.20NA
Q1 2020
5/7/2020
104.60-3.90-12.20NA
Q4 2019
3/13/2020
91.10-3.10-11.30NA
Q3 2019
11/6/2019
142.20-2.40-11.20NA
Q2 2019
8/7/2019
109.30-2.80-11.50NA
Q1 2019
5/7/2019
90.50-3.00NANA
Q4 2018
3/7/2019
117.60-3.00NANA
Q3 2018
11/7/2018
133.40-2.70NANA
Quotes delayed 20 minutes

Email EnvelopeFree VRCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Verrica Pharmaceuticals (VRCA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VRDN PE Ratio History
VREX PE Ratio History
VRPX PE Ratio History
VRTX PE Ratio History
VSTM PE Ratio History
VTGN PE Ratio History
VTRS PE Ratio History
VTVT PE Ratio History
VTYX PE Ratio History
VVOS PE Ratio History
How should the VRCA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Verrica Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this VRCA Historical PE Ratio page.

What is the average historical PE for VRCA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The VRCA historical PE ratio using the annualized quarterly earnings method works out to 7.7.

What is the average historical PE for VRCA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The VRCA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the VRCA Historical PE Ratio information for Verrica Pharmaceuticals' stock. The average VRCA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 7.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VRCA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VRCA historical PE result, against the recent PE: when this page was posted on 11/10/2025, the most recent closing price for VRCA had been 3.87, and the most recent quarterly earnings result, annualized, was 1. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent VRCA PE on 11/10/2025 based on annualized quarterly EPS was 3.9. Based on VRCA's history, that recent PE is low relative to the historical average, with the recent PE 49.4% lower than the historical average PE across our data set for Verrica Pharmaceuticals.

For self directed investors doing their due diligence on VRCA or any other given stock, valuation analysis for VRCA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Verrica Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VRCA. Thanks for visiting, and the next time you need to research VRCA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: EDGU Videos, ESEA Options Chain, ANGI market cap history.

 

VRCA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2025, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.